U.S. Telecom Services and Carriers Stock News

In recent months, Chinese regulators launched an antitrust review into competition practices in the food delivery sector, scrutinizing subsidy-driven price wars among major platforms including JD.com. This clampdown on aggressive discounting could ease pressure on JD.com’s margins, intersecting with the company’s broader push into food delivery and logistics-heavy services. We will now examine how this antitrust probe into food delivery subsidies may reshape JD.com’s investment narrative...

With no single headline driving attention today, UnitedHealth Group (UNH) sits in focus as investors weigh its recent share performance against a large, diversified health care business that spans insurance, pharmacy services, and data driven health solutions. See our latest analysis for UnitedHealth Group. Recent trading has been subdued, with a 1 day share price decline of 1.01% to US$340.51 and a 90 day share price decline of 5.40%, while the 1 year total shareholder return decline of...

Owens Corning (OC) has come into focus after a recent shift in earnings estimates and a cautious tone from analysts, even as several firms keep positive recommendations in place for the building products company. See our latest analysis for Owens Corning. The recent 8.22% 7 day share price return and 6.03% 30 day share price return at a last close of US$123 sit against a 25.81% total shareholder return decline over one year and a 61.42% total shareholder return gain over five years. This...

In its recently reported third quarter of fiscal 2026, Constellation Brands posted lower year-on-year sales and earnings, yet still exceeded analyst expectations and reaffirmed its full-year outlook while continuing dividends and share repurchases. Despite pressures on beer volumes and softer spending by key Hispanic consumers, the company preserved strong beer margins and highlighted steady demand for core brands like Corona and Modelo Especial, underlining the resilience of its portfolio...

Earlier this month, SES AI Corporation presented at CES 2026 in Las Vegas and the Gordon Research Conference on Electrochemistry in Ventura, highlighting its latest advances in AI-enhanced battery technology. By sharing its electrochemistry research and AI-driven materials work on such high-profile stages, SES AI is potentially reinforcing its positioning with both technology partners and prospective enterprise users of its Molecular Universe platform. Next, we’ll explore how SES AI’s...

Recent commentary from major banks, including a downgrade of Nucor (NUE) by Morgan Stanley, alongside increased confidence in its prospects, has pushed the stock into focus for investors weighing steel sector exposure. See our latest analysis for Nucor. At a share price of US$165.97, Nucor has recently seen a 1 day share price return of 1.34% and a 90 day share price return of 19.83%, while its 1 year total shareholder return of 37.27% and 5 year total shareholder return of 223.44% point to...

MGIC Investment (MTG) has been drawing attention after recent share price swings, with the stock down about 4% over the past month but modestly positive over the past 3 months. See our latest analysis for MGIC Investment. Zooming out, MGIC Investment’s recent 1 month share price return of around a 4% decline and a softer 7 day move sit against a 1 year total shareholder return of 22.94%. This suggests momentum has cooled even as long term holders have seen solid gains. If MGIC’s recent...

A major US automaker’s decision to use Mobileye Global (MBLY) EyeQ6H chips for hands-free driving across millions of vehicles puts the company’s Surround ADAS technology at the center of evolving software-defined car platforms. See our latest analysis for Mobileye Global. Despite the new automaker deal and the planned Mentee Robotics acquisition, Mobileye’s share price return has been mixed, with a 30 day share price return of 3.34% but a 1 year total shareholder return decline of 26.99%,...

If you are wondering whether AbbVie’s current share price reflects its underlying value, you are not alone. This article will walk through what the market might be pricing in. AbbVie recently closed at US$220.04, with a 0.1% decline over 7 days, a 1.5% decline over 30 days, a 4.0% decline year to date, but a 28.9% return over 1 year, 58.4% over 3 years and 139.2% over 5 years, which may prompt questions about how much optimism or risk is already in the price. Recent headlines around AbbVie...

Earlier this month, Maximus announced that its Board of Directors approved a quarterly cash dividend of US$0.33 per share, a 10% increase from the prior US$0.30, payable on March 2, 2026 to shareholders of record on February 13, 2026. This higher dividend underscores management’s willingness to return more cash to shareholders, which may reinforce perceptions of balance sheet strength and earnings resilience. We’ll now explore how this 10% dividend increase interacts with Maximus’ existing...

Conference updates and pipeline focus Vertex Pharmaceuticals (VRTX) has drawn fresh attention after outlining business and program updates ahead of its webcast at the 44th annual J.P. Morgan Healthcare Conference on January 12, 2026. See our latest analysis for Vertex Pharmaceuticals. Vertex’s recent program updates come after a steady run in the market, with a 90 day share price return of 11.73% and a 5 year total shareholder return of 104.21%, suggesting momentum has been building around...

PTC (PTC) is back on investors’ radar after recent share price softness, with the stock down over the past month and past 3 months. This has prompted fresh questions about how its software fundamentals line up with the current valuation. See our latest analysis for PTC. That recent 15.16% 90 day share price decline, alongside a 2.60% 30 day share price pullback, sits against a 0.78% year to date share price return and a mixed picture on longer term total shareholder returns, with gains over...

CRH (CRH) is back in focus after a series of bullish analyst updates, an active share buyback program of up to US$300 million, and a clear tilt toward North American infrastructure and construction demand. See our latest analysis for CRH. Those buybacks and analyst updates come at a time when CRH’s 90 day share price return of 9.37% and 1 year total shareholder return of 45.08% suggest momentum has been building on top of a multi year compounding story. If CRH’s U.S. focused construction...

If you are wondering whether Sun Communities is reasonably priced at around US$124 per share, you are not alone, as the stock often raises questions about what you are really paying for. Over the last year the share price return is 8.3%, with shorter term moves of 2.4% over 7 days and 1.5% over 30 days. These moves may signal that the market is reassessing either its growth potential or its risks. Recent attention around Sun Communities has focused on its position in the real estate sector...

Zeta Global Holdings announced a collaboration with OpenAI to enhance its Athena AI marketing platform, accelerated the Athena Suite rollout to late first quarter 2026, and recently closed its acquisition of Marigold, while also preparing for a fireside chat at the Needham Growth Conference held on 13 January 2026 in New York. This combination of an OpenAI-powered product roadmap, an expanded marketing software portfolio via Marigold, and near-term investor outreach has sharpened attention...

In January 2026, Joby Aviation announced it had accepted the first of two advanced flight simulators developed with CAE, designed for high-level FAA qualification to support commercial single-pilot eVTOL operations. The simulators use CAE’s next-generation image generator built on Unreal Engine and AI-crafted 3D urban environments to recreate complex, real-world air taxi conditions for pilot training. We’ll now explore how this move into high-fidelity, FAA-ready pilot training...

Fresh interest in Eli Lilly stock Eli Lilly (LLY) has drawn investor attention after a recent move in its share price, with the stock last closing at $1,081 and showing double digit total returns over the past year. See our latest analysis for Eli Lilly. The recent share price move sits on top of a strong run, with a 33.07% 3 month share price return and a 36.56% 1 year total shareholder return, pointing to momentum that investors appear to be rewarding as perceptions around growth potential...

Why lululemon athletica (LULU) is back on investors’ radar lululemon athletica (LULU) has been drawing attention after a mixed stretch for shareholders, with the stock showing a 23.6% gain over the past 3 months but a 47.6% decline over the past year. See our latest analysis for lululemon athletica. While the recent 90 day share price return of 23.6% suggests some momentum has come back into the stock, the 1 year total shareholder return of a 47.6% decline shows longer term holders are still...

Emerson Electric (EMR) is back in focus after UBS upgraded the stock to Buy and raised its target, just as investors brace for the company’s upcoming fiscal Q1 2026 earnings announcement. See our latest analysis for Emerson Electric. The recent UBS upgrade comes on top of steady momentum, with Emerson’s share price at US$145.36 and supported by a 30 day share price return of 6.38% and a 1 year total shareholder return of 24.79%. The 3 year total shareholder return of 57.51% signals that...

Cal-Maine Foods (CALM) just reported second quarter results showing lower sales and earnings compared with a year earlier, along with a reduced variable dividend and an update on its recently completed share repurchase program. See our latest analysis for Cal-Maine Foods. That weaker quarterly result and lower variable dividend come alongside a softer share price, with a 30 day share price return of a 15% decline and a 90 day share price return of a 20.8% decline, even though the 5 year total...

In recent months, Geneos Wealth Management Inc. very largely increased its stake in Dorchester Minerals, L.P., while CEO Bradley J. Ehrman also added shares, coinciding with the partnership raising its quarterly distribution to US$0.6899 per unit. Taken together, the higher cash payout and additional insider and institutional ownership highlight management’s and investors’ willingness to commit more capital to the business. With the dividend increase as a key focal point, we’ll now examine...

Lam Research (LRCX) has been catching investor attention after a sharp move in the share price, with returns of 37% over the past month and 59% over the past 3 months drawing closer scrutiny. See our latest analysis for Lam Research. Those sharp recent share price returns sit on top of a much longer run, with Lam Research posting a very large 1 year total shareholder return. The 3 year and 5 year total shareholder returns are also strong, suggesting momentum is still building as investors...

If you are wondering whether Cisco Systems' current share price still lines up with its underlying worth, this article will walk through what the numbers actually say. Cisco closed at US$74.01, with a 2.1% decline over the last 7 days and a 4.9% decline over the last 30 days, set against a 29.0% return over 1 year, 64.9% over 3 years and 88.3% over 5 years. Recent coverage has focused on Cisco's position as a large networking and infrastructure provider, and how market views on long term...

Churchill Downs Incorporated recently outlined development plans for its Rockingham Grand Casino in Salem, New Hampshire, a US$180–200 million project set within The Mall at Rockingham Park near the mixed-use Tuscan Village complex. This expansion reinforces Churchill Downs’ push into experiential regional gaming, adding a sizable New Hampshire presence alongside its existing Casino Salem charitable gaming facility. Next, we’ll assess how the planned Rockingham Grand Casino’s US$180–200...